Immunodiagnostics Market by Product, Application, and Geography - Forecast and Analysis 2023-2027

Published: Oct 2023 Pages: 169 SKU: IRTNTR44345

Immunodiagnostics Market Forecast 2023-2027

The Global Immunodiagnostics Market size is forecast to increase by USD 22.67 billion at a CAGR of 12% between 2022 and 2027. The market witnesses growth driven by key factors in the healthcare sector. With an increased demand for biomarker-based tests, there's a heightened focus on early disease detection and personalized medicine. Furthermore, advancements in technology in immunodiagnostics enhance diagnostic accuracy and efficiency, meeting the evolving needs of healthcare professionals. Additionally, the rising geriatric population contributes to market expansion, as age-related illnesses drive demand for diagnostic solutions. This dynamic market landscape underscores the pivotal role of immunodiagnostics in shaping modern healthcare practices globally. This market research and growth report also includes an in-depth analysis of drivers, trends, and challenges. Furthermore, the report includes historic market data from 2017 to 2021.

What will be the Size of the Immunodiagnostics Market During the Forecast Period?

To learn more about this report, View Report Sample

Market Segmentation

The market share growth by the reagents and consumables segment will be significant during the forecast period. The reagents and consumables segment is expected to increase rapidly compared with the immunodiagnostic instruments market. The high demand for high-throughput screening with the help of immunoassays has led to the production of new reagents to detect antigens. The implementation of fluorescence and chemiluminescence technology with new reagents has also increased in the market.

Get a glance at the market contribution of various segments View the PDF Sample

The reagents and consumables segment was valued at USD 16.32 billion in 2017 and continued to grow until 2021. The high demand for high-throughput screening with the help of immunoassays has led to the production of new reagents. The implementation of fluorescence and chemiluminescence technology with new reagents has also increased in the market. The growing number of immunodiagnostic tests available in the market compels companies to increase their product portfolio for test reagents. Such factors will increase segment growth during the forecast period.

Which are the Key Regions for the Immunodiagnostics Market?

For more insights on the market share of various regions Download PDF Sample now!

North America is estimated to contribute 35% to the growth of the global market during the forecast period. Technavio’s analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. The market growth is driven by factors such as the rise in the geriatric population, increasing healthcare expenditure, and the need for early diagnosis and effective treatment of diseases. Moreover, increased awareness among the population has resulted in people undergoing regular tests and checkups, which has increased the sales of immunodiagnostic devices in the country. In the US, the number of people diagnosed with diabetes is increasing. Also, adult obesity in the country is increasing. Obesity-related conditions include heart disease, stroke, type 2 diabetes, and certain types of cancer, which are some of the leading causes of preventable, premature death. Hence, these factors can increase the demand for immunodiagnostics in the region during the forecast period.

Market Dynamics and Customer Landscape

The market addresses a wide range of diseases, including infectious diseases, cardiovascular diseases, cancer, gastrointestinal diseases, and chronic diseases, catering to the growing geriatric population and changing demographics. Utilizing advanced diagnosis kits, analyzers, and immunodiagnostics technologies, it enables early detection and diagnosis of conditions such as STI, Hepatitis B, and autoimmune diseases, enhancing patient outcomes and reducing healthcare expenditures. This market's supply chain network and cost management strategies support the efficient delivery of reagents, assays, and diagnostic solutions, particularly in developed nations with aging populations. Our researchers analyzed the data with 2022 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

Key Market Driver

Increased demand for biomarker-based tests is one of the key factors driving the growth of the global immunodiagnostics market growth. Leveraging sophisticated research and development in nucleic acid expression, proteomics, and sequencing has facilitated the emergence of biomarkers. These molecular entities, encompassing proteins, genes, and hormones, serve as critical indicators for disease detection. Technological advancements are compelling manufacturers to devise assays tailored to burgeoning clinical domains like cancer, cardiovascular diseases, and women's health. Consequently, traditional drug therapies are gradually being supplanted, fostering increased revenue from personalized testing device sales.

In response to market dynamics, numerous companies are endeavoring to develop cost-effective biomarker-based tests, aiming to bolster their market penetration. Furthermore, the heightened approval of devices by regulatory authorities for such tests, strategic partnerships among industry players, and a proliferation of product launches are anticipated to further fuel the growth trajectory of the market throughout the forecast period.

Significant Market Trends

Growth in demand for personalized medicine will fuel the global immunodiagnostics market growth. There is a growing trend toward personalized medicine, which requires precision diagnostics. Immunodiagnostics plays a key role in precision medicine by enabling accurate diagnosis and monitoring of diseases at the molecular level. Personalized medicine refers to the tailoring of medical treatment to the individual characteristics of each patient. Prescribing the medicines to individuals by accurate diagnosis by age, disease, gender, and criticality of disease. This approach requires precise diagnostic tests that can accurately identify specific biomarkers and molecular targets for different diseases. Immunodiagnostics plays a critical role in precision medicine by providing high sensitivity and specificity for the detection of disease biomarkers.

In recent years, there has been a growing demand for personalized medicine, particularly for the treatment of cancer and autoimmune diseases. Immunodiagnostics enables the identification of specific targets for these diseases, which can help clinicians select the most effective treatment options for individual patients. Hence, the global immunodiagnostics market is expected to grow during the forecast period as personalized medicine becomes more prevalent. Such factors will increase the market growth during the forecast period.

Major Market Challenge

The high cost of immunodiagnostics tests is a major challenge impeding the global immunodiagnostics market growth. The high cost of immunodiagnostic tests is a major challenge in the global immunodiagnostics market. Immunodiagnostic testing can be expensive and can limit patient access to care. This is especially true in low- and middle-income countries where resources may be limited. Immunodiagnostic tests are complex and require sophisticated techniques, specialized equipment, and highly skilled personnel, all of which contribute to the high cost of these tests. Additionally, the cost of raw materials and reagents used in immunodiagnostic tests is also high, adding to the overall cost of these tests. 

The high cost of immunodiagnostic tests can be a significant barrier to access for patients, particularly in developing countries where healthcare budgets are limited. This can lead to underdiagnosis and delayed treatment, which can have serious consequences for patient outcomes. Moreover, the high cost of these tests can also limit their adoption in certain clinical settings, where there may be cost constraints or limitations on reimbursement. Therefore, the high cost of immunodiagnostics tests will hamper the growth of the global immunodiagnostics market during the forecast period.

Customer Landscape

The report includes the adoption lifecycle of the market, covering from the innovator’s stage to the laggard’s stage. It focuses on adoption rates in different regions based on penetration. Furthermore, the report also includes key purchase criteria and drivers of price sensitivity to help companies evaluate and develop their growth strategies.

Global Immunodiagnostics Market Customer Landscape

Who are the Major Immunodiagnostics Market Companies?

Companies are implementing various strategies, such as strategic alliances, partnerships, mergers and acquisitions, geographical expansion, and product/service launches, to enhance their presence in the market.

Adaptive Biotechnologies Corp.: The company offers immunodiagnostics solutions such as clonoSEQ and immunoSEQ Dx. Also, the company focuses on providing immune-driven medicine. 

The report also includes detailed analyses of the competitive landscape of the market and information about 15 market Companies, including:

  • Abbott Laboratories
  • AESKU.GROUP GmbH and Co. KG
  • bioMerieux SA
  • Danaher Corp.
  • Exagen Inc.
  • F. Hoffmann La Roche Ltd.
  • HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
  • Nexus Dx Inc.
  • Omega Diagnostics Group Plc
  • QuidelOrtho Corp.
  • Seramun Diagnostica GmbH
  • Siemens AG
  • SQI Diagnostics Inc.
  • Sysmex Corp.
  • Thermo Fisher Scientific Inc.

Qualitative and quantitative analysis of Companies has been conducted to help clients understand the wider business environment as well as the strengths and weaknesses of key market players. Data is qualitatively analyzed to categorize Companies as pure play, category-focused, industry-focused, and diversified; it is quantitatively analyzed to categorize Companies as dominant, leading, strong, tentative, and weak.

Market Analyst Overview

The market is witnessing robust growth due to the increasing prevalence of infectious diseases, cardiovascular diseases, and gastrointestinal diseases across different demographics and lifestyles. Advanced diagnosis kits and analyzers play a crucial role in early detection, leveraging Antigen antibody reactions for accurate results. With rising cases of autoimmunity diseases like Hepatitis B, particularly among the aged population, the demand for immunodiagnostics is on the rise. Pathologists utilize these tools to manage healthcare expenditures effectively while ensuring efficient supply chain networks for reagents & consumables. Investments in research & development drive innovation and cost management, especially in developed nations, focusing on the prevention of diseases in fields like oncology & endocrinology.

The market is pivotal in addressing the rising burden of chronic diseases worldwide. Through innovative immunoassay techniques and technological advancements, it facilitates early detection and management of various conditions, including autoimmune disorders. Robust patient epidemiology and pipeline analysis aid in understanding disease trends and developing targeted solutions. Key technologies like chemiluminescence immunoassay (CLIA) and enzyme-linked immunosorbent assay (ELISA) enable accurate biomarker discovery for precise diagnosis. However, challenges such as stringent regulatory requirements and technical limitations underscore the need for continuous innovation and adherence to the regulatory framework. Despite these hurdles, the market thrives with an increased focus on preventive health measures and the growing demand for in vitro diagnostics in hospitals and clinics.

Segment Overview

The immunodiagnostics market report forecasts market growth by revenue at global, regional & country levels and provides an aalysis of the latest trends and growth opportunities from 2017 to 2027. 

  • Deployment Outlook 
    • Reagents and consumables
    • Immunodiagnostic systems
  • Application Outlook 
    • Oncology and endocrinology
    • Hepatitis and retrovirus
    • Infectious disease
    • GI stool
    • Others
  • Region Outlook 
    • North America
      • The U.S.
      • Canada
    • Europe
      • The U.K.
      • Germany
      • France
      • Rest of Europe
    • ASIA
      • China
      • India
    • ROW
      • Argentina
      • Australia
      • Rest of the world

Immunodiagnostics Market Scope

Report Coverage

Details

Page number

169

Base year

2022

Historic period

2017-2021

Forecast period

2023-2027

Growth momentum & CAGR

Accelerate at a CAGR of 12%

Market growth 2023-2027

USD 22.67 billion

Market structure

Fragmented

YoY growth 2022-2023(%)

11.0

Regional analysis

North America, Europe, Asia, and Rest of World (ROW)

Performing market contribution

North America at 35%

Key countries

US, Canada, UK, Germany, and China

Competitive landscape

 Leading Companies, Market Positioning of Companies, Competitive Strategies, and Industry Risks

Key companies profiled

Abbott Laboratories, Adaptive Biotechnologies Corp., AESKU.GROUP GmbH and Co. KG, bioMerieux SA, Danaher Corp., Exagen Inc., F. Hoffmann La Roche Ltd., HUMAN Gesellschaft fur Biochemica und Diagnostica mbH, Nexus Dx Inc., Omega Diagnostics Group Plc, QuidelOrtho Corp., Seramun Diagnostica GmbH, Siemens AG, SQI Diagnostics Inc., Sysmex Corp., Thermo Fisher Scientific Inc., Werfenlife SA, Tecan Trading AG, OraSure Technologies Inc., and DiaSorin SpA

Market dynamics

Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for forecast period.

Customization purview

If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized.

View PDF Sample

What are the Key Data Covered in this Market Research Report?

  • CAGR of the market during the forecast period
  • Detailed information on factors that will drive the market growth and forecasting between 2023 and 2027
  • Precise estimation of the market size and its contribution of the market in focus to the parent market
  • Accurate predictions about upcoming trends and changes in consumer behavior
  • Market growth analysis across North America, Europe, Asia, and Rest of World (ROW)
  • Thorough analysis of the market’s competitive landscape and detailed information about companies
  • Market forecasting of factors that will challenge the growth of market companies

We can help! Our analysts can customize this market research report to meet your requirements. 

Get in touch

1 Executive Summary

  • 1.1 Market overview
    • Exhibit 01: Executive Summary – Chart on Market Overview
    • Exhibit 02: Executive Summary – Data Table on Market Overview
    • Exhibit 03: Executive Summary – Chart on Global Market Characteristics
    • Exhibit 04: Executive Summary – Chart on Market by Geography
    • Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
    • Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
    • Exhibit 07: Executive Summary – Chart on Incremental Growth
    • Exhibit 08: Executive Summary – Data Table on Incremental Growth
    • Exhibit 09: Executive Summary – Chart on Vendor Market Positioning

2 Market Landscape

  • 2.1 Market ecosystem
    • Exhibit 10: Parent market
    • Exhibit 11: Market Characteristics

3 Market Sizing

  • 3.1 Market definition
    • Exhibit 12: Offerings of vendors included in the market definition
  • 3.2 Market segment analysis
    • Exhibit 13: Market segments
  • 3.3 Market size 2022
    • 3.4 Market outlook: Forecast for 2022-2027
      • Exhibit 14: Chart on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 15: Data Table on Global - Market size and forecast 2022-2027 ($ million)
      • Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
      • Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)

    4 Historic Market Size

    • 4.1 Global immunodiagnostics market 2017 - 2021
      • Exhibit 18: Historic Market Size – Data Table on global immunodiagnostics market 2017 - 2021 ($ million)
    • 4.2 Product Segment Analysis 2017 - 2021
      • Exhibit 19: Historic Market Size – Product Segment 2017 - 2021 ($ million)
    • 4.3 Application Segment Analysis 2017 - 2021
      • Exhibit 20: Historic Market Size – Application Segment 2017 - 2021 ($ million)
    • 4.4 Geography Segment Analysis 2017 - 2021
      • Exhibit 21: Historic Market Size – Geography Segment 2017 - 2021 ($ million)
    • 4.5 Country Segment Analysis 2017 - 2021
      • Exhibit 22: Historic Market Size – Country Segment 2017 - 2021 ($ million)

    5 Five Forces Analysis

    • 5.1 Five forces summary
      • Exhibit 23: Five forces analysis - Comparison between 2022 and 2027
    • 5.2 Bargaining power of buyers
      • Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
    • 5.3 Bargaining power of suppliers
      • Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
    • 5.4 Threat of new entrants
      • Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
    • 5.5 Threat of substitutes
      • Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
    • 5.6 Threat of rivalry
      • Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
    • 5.7 Market condition
      • Exhibit 29: Chart on Market condition - Five forces 2022 and 2027

    6 Market Segmentation by Product

    • 6.1 Market segments
      • Exhibit 30: Chart on Product - Market share 2022-2027 (%)
      • Exhibit 31: Data Table on Product - Market share 2022-2027 (%)
    • 6.2 Comparison by Product
      • Exhibit 32: Chart on Comparison by Product
      • Exhibit 33: Data Table on Comparison by Product
    • 6.3 Reagents and consumables - Market size and forecast 2022-2027
      • Exhibit 34: Chart on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
      • Exhibit 35: Data Table on Reagents and consumables - Market size and forecast 2022-2027 ($ million)
      • Exhibit 36: Chart on Reagents and consumables - Year-over-year growth 2022-2027 (%)
      • Exhibit 37: Data Table on Reagents and consumables - Year-over-year growth 2022-2027 (%)
    • 6.4 Immunodiagnostic systems - Market size and forecast 2022-2027
      • Exhibit 38: Chart on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
      • Exhibit 39: Data Table on Immunodiagnostic systems - Market size and forecast 2022-2027 ($ million)
      • Exhibit 40: Chart on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
      • Exhibit 41: Data Table on Immunodiagnostic systems - Year-over-year growth 2022-2027 (%)
    • 6.5 Market opportunity by Product
      • Exhibit 42: Market opportunity by Product ($ million)
      • Exhibit 43: Data Table on Market opportunity by Product ($ million)

    7 Market Segmentation by Application

    • 7.1 Market segments
      • Exhibit 44: Chart on Application - Market share 2022-2027 (%)
      • Exhibit 45: Data Table on Application - Market share 2022-2027 (%)
    • 7.2 Comparison by Application
      • Exhibit 46: Chart on Comparison by Application
      • Exhibit 47: Data Table on Comparison by Application
    • 7.3 Oncology and endocrinology - Market size and forecast 2022-2027
      • Exhibit 48: Chart on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 49: Data Table on Oncology and endocrinology - Market size and forecast 2022-2027 ($ million)
      • Exhibit 50: Chart on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
      • Exhibit 51: Data Table on Oncology and endocrinology - Year-over-year growth 2022-2027 (%)
    • 7.4 Hepatitis and retrovirus - Market size and forecast 2022-2027
      • Exhibit 52: Chart on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
      • Exhibit 53: Data Table on Hepatitis and retrovirus - Market size and forecast 2022-2027 ($ million)
      • Exhibit 54: Chart on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
      • Exhibit 55: Data Table on Hepatitis and retrovirus - Year-over-year growth 2022-2027 (%)
    • 7.5 Infectious disease - Market size and forecast 2022-2027
      • Exhibit 56: Chart on Infectious disease - Market size and forecast 2022-2027 ($ million)
      • Exhibit 57: Data Table on Infectious disease - Market size and forecast 2022-2027 ($ million)
      • Exhibit 58: Chart on Infectious disease - Year-over-year growth 2022-2027 (%)
      • Exhibit 59: Data Table on Infectious disease - Year-over-year growth 2022-2027 (%)
    • 7.6 GI stool - Market size and forecast 2022-2027
      • Exhibit 60: Chart on GI stool - Market size and forecast 2022-2027 ($ million)
      • Exhibit 61: Data Table on GI stool - Market size and forecast 2022-2027 ($ million)
      • Exhibit 62: Chart on GI stool - Year-over-year growth 2022-2027 (%)
      • Exhibit 63: Data Table on GI stool - Year-over-year growth 2022-2027 (%)
    • 7.7 Other applications - Market size and forecast 2022-2027
      • Exhibit 64: Chart on Other applications - Market size and forecast 2022-2027 ($ million)
      • Exhibit 65: Data Table on Other applications - Market size and forecast 2022-2027 ($ million)
      • Exhibit 66: Chart on Other applications - Year-over-year growth 2022-2027 (%)
      • Exhibit 67: Data Table on Other applications - Year-over-year growth 2022-2027 (%)
    • 7.8 Market opportunity by Application
      • Exhibit 68: Market opportunity by Application ($ million)
      • Exhibit 69: Data Table on Market opportunity by Application ($ million)

    8 Customer Landscape

    • 8.1 Customer landscape overview
      • Exhibit 70: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

    9 Geographic Landscape

    • 9.1 Geographic segmentation
      • Exhibit 71: Chart on Market share by geography 2022-2027 (%)
      • Exhibit 72: Data Table on Market share by geography 2022-2027 (%)
    • 9.2 Geographic comparison
      • Exhibit 73: Chart on Geographic comparison
      • Exhibit 74: Data Table on Geographic comparison
    • 9.3 North America - Market size and forecast 2022-2027
      • Exhibit 75: Chart on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 76: Data Table on North America - Market size and forecast 2022-2027 ($ million)
      • Exhibit 77: Chart on North America - Year-over-year growth 2022-2027 (%)
      • Exhibit 78: Data Table on North America - Year-over-year growth 2022-2027 (%)
    • 9.4 Europe - Market size and forecast 2022-2027
      • Exhibit 79: Chart on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 80: Data Table on Europe - Market size and forecast 2022-2027 ($ million)
      • Exhibit 81: Chart on Europe - Year-over-year growth 2022-2027 (%)
      • Exhibit 82: Data Table on Europe - Year-over-year growth 2022-2027 (%)
    • 9.5 Asia - Market size and forecast 2022-2027
      • Exhibit 83: Chart on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 84: Data Table on Asia - Market size and forecast 2022-2027 ($ million)
      • Exhibit 85: Chart on Asia - Year-over-year growth 2022-2027 (%)
      • Exhibit 86: Data Table on Asia - Year-over-year growth 2022-2027 (%)
    • 9.6 Rest of World (ROW) - Market size and forecast 2022-2027
      • Exhibit 87: Chart on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 88: Data Table on Rest of World (ROW) - Market size and forecast 2022-2027 ($ million)
      • Exhibit 89: Chart on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
      • Exhibit 90: Data Table on Rest of World (ROW) - Year-over-year growth 2022-2027 (%)
    • 9.7 US - Market size and forecast 2022-2027
      • Exhibit 91: Chart on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 92: Data Table on US - Market size and forecast 2022-2027 ($ million)
      • Exhibit 93: Chart on US - Year-over-year growth 2022-2027 (%)
      • Exhibit 94: Data Table on US - Year-over-year growth 2022-2027 (%)
    • 9.8 UK - Market size and forecast 2022-2027
      • Exhibit 95: Chart on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 96: Data Table on UK - Market size and forecast 2022-2027 ($ million)
      • Exhibit 97: Chart on UK - Year-over-year growth 2022-2027 (%)
      • Exhibit 98: Data Table on UK - Year-over-year growth 2022-2027 (%)
    • 9.9 Germany - Market size and forecast 2022-2027
      • Exhibit 99: Chart on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 100: Data Table on Germany - Market size and forecast 2022-2027 ($ million)
      • Exhibit 101: Chart on Germany - Year-over-year growth 2022-2027 (%)
      • Exhibit 102: Data Table on Germany - Year-over-year growth 2022-2027 (%)
    • 9.10 Canada - Market size and forecast 2022-2027
      • Exhibit 103: Chart on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 104: Data Table on Canada - Market size and forecast 2022-2027 ($ million)
      • Exhibit 105: Chart on Canada - Year-over-year growth 2022-2027 (%)
      • Exhibit 106: Data Table on Canada - Year-over-year growth 2022-2027 (%)
    • 9.11 China - Market size and forecast 2022-2027
      • Exhibit 107: Chart on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 108: Data Table on China - Market size and forecast 2022-2027 ($ million)
      • Exhibit 109: Chart on China - Year-over-year growth 2022-2027 (%)
      • Exhibit 110: Data Table on China - Year-over-year growth 2022-2027 (%)
    • 9.12 Market opportunity by geography
      • Exhibit 111: Market opportunity by geography ($ million)
      • Exhibit 112: Data Tables on Market opportunity by geography ($ million)

    10 Drivers, Challenges, and Trends

    • 10.1 Market drivers
      • 10.2 Market challenges
        • 10.3 Impact of drivers and challenges
          • Exhibit 113: Impact of drivers and challenges in 2022 and 2027
        • 10.4 Market trends

          11 Vendor Landscape

          • 11.1 Overview
            • 11.2 Vendor landscape
              • Exhibit 114: Overview on Criticality of inputs and Factors of differentiation
            • 11.3 Landscape disruption
              • Exhibit 115: Overview on factors of disruption
            • 11.4 Industry risks
              • Exhibit 116: Impact of key risks on business

            12 Vendor Analysis

            • 12.1 Vendors covered
              • Exhibit 117: Vendors covered
            • 12.2 Market positioning of vendors
              • Exhibit 118: Matrix on vendor position and classification
            • 12.3 Abbott Laboratories
              • Exhibit 119: Abbott Laboratories - Overview
              • Exhibit 120: Abbott Laboratories - Business segments
              • Exhibit 121: Abbott Laboratories - Key news
              • Exhibit 122: Abbott Laboratories - Key offerings
              • Exhibit 123: Abbott Laboratories - Segment focus
            • 12.4 Adaptive Biotechnologies Corp.
              • Exhibit 124: Adaptive Biotechnologies Corp. - Overview
              • Exhibit 125: Adaptive Biotechnologies Corp. - Product / Service
              • Exhibit 126: Adaptive Biotechnologies Corp. - Key offerings
            • 12.5 AESKU.GROUP GmbH and Co. KG
              • Exhibit 127: AESKU.GROUP GmbH and Co. KG - Overview
              • Exhibit 128: AESKU.GROUP GmbH and Co. KG - Product / Service
              • Exhibit 129: AESKU.GROUP GmbH and Co. KG - Key offerings
            • 12.6 bioMerieux SA
              • Exhibit 130: bioMerieux SA - Overview
              • Exhibit 131: bioMerieux SA - Product / Service
              • Exhibit 132: bioMerieux SA - Key offerings
            • 12.7 Danaher Corp.
              • Exhibit 133: Danaher Corp. - Overview
              • Exhibit 134: Danaher Corp. - Business segments
              • Exhibit 135: Danaher Corp. - Key news
              • Exhibit 136: Danaher Corp. - Key offerings
              • Exhibit 137: Danaher Corp. - Segment focus
            • 12.8 DiaSorin SpA
              • Exhibit 138: DiaSorin SpA - Overview
              • Exhibit 139: DiaSorin SpA - Business segments
              • Exhibit 140: DiaSorin SpA - Key news
              • Exhibit 141: DiaSorin SpA - Key offerings
              • Exhibit 142: DiaSorin SpA - Segment focus
            • 12.9 F. Hoffmann La Roche Ltd.
              • Exhibit 143: F. Hoffmann La Roche Ltd. - Overview
              • Exhibit 144: F. Hoffmann La Roche Ltd. - Business segments
              • Exhibit 145: F. Hoffmann La Roche Ltd. - Key news
              • Exhibit 146: F. Hoffmann La Roche Ltd. - Key offerings
              • Exhibit 147: F. Hoffmann La Roche Ltd. - Segment focus
            • 12.10 HUMAN Gesellschaft fur Biochemica und Diagnostica mbH
              • Exhibit 148: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Overview
              • Exhibit 149: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Product / Service
              • Exhibit 150: HUMAN Gesellschaft fur Biochemica und Diagnostica mbH - Key offerings
            • 12.11 OraSure Technologies Inc.
              • Exhibit 151: OraSure Technologies Inc. - Overview
              • Exhibit 152: OraSure Technologies Inc. - Business segments
              • Exhibit 153: OraSure Technologies Inc. - Key offerings
              • Exhibit 154: OraSure Technologies Inc. - Segment focus
            • 12.12 QuidelOrtho Corp.
              • Exhibit 155: QuidelOrtho Corp. - Overview
              • Exhibit 156: QuidelOrtho Corp. - Product / Service
              • Exhibit 157: QuidelOrtho Corp. - Key offerings
            • 12.13 Siemens AG
              • Exhibit 158: Siemens AG - Overview
              • Exhibit 159: Siemens AG - Business segments
              • Exhibit 160: Siemens AG - Key news
              • Exhibit 161: Siemens AG - Key offerings
              • Exhibit 162: Siemens AG - Segment focus
            • 12.14 SQI Diagnostics Inc.
              • Exhibit 163: SQI Diagnostics Inc. - Overview
              • Exhibit 164: SQI Diagnostics Inc. - Product / Service
              • Exhibit 165: SQI Diagnostics Inc. - Key offerings
            • 12.15 Sysmex Corp.
              • Exhibit 166: Sysmex Corp. - Overview
              • Exhibit 167: Sysmex Corp. - Business segments
              • Exhibit 168: Sysmex Corp. - Key offerings
              • Exhibit 169: Sysmex Corp. - Segment focus
            • 12.16 Tecan Trading AG
              • Exhibit 170: Tecan Trading AG - Overview
              • Exhibit 171: Tecan Trading AG - Business segments
              • Exhibit 172: Tecan Trading AG - Key offerings
              • Exhibit 173: Tecan Trading AG - Segment focus
            • 12.17 Thermo Fisher Scientific Inc.
              • Exhibit 174: Thermo Fisher Scientific Inc. - Overview
              • Exhibit 175: Thermo Fisher Scientific Inc. - Business segments
              • Exhibit 176: Thermo Fisher Scientific Inc. - Key news
              • Exhibit 177: Thermo Fisher Scientific Inc. - Key offerings
              • Exhibit 178: Thermo Fisher Scientific Inc. - Segment focus

            13 Appendix

            • 13.1 Scope of the report
              • 13.2 Inclusions and exclusions checklist
                • Exhibit 179: Inclusions checklist
                • Exhibit 180: Exclusions checklist
              • 13.3 Currency conversion rates for US$
                • Exhibit 181: Currency conversion rates for US$
              • 13.4 Research methodology
                • Exhibit 182: Research methodology
                • Exhibit 183: Validation techniques employed for market sizing
                • Exhibit 184: Information sources
              • 13.5 List of abbreviations
                • Exhibit 185: List of abbreviations

              Research Framework

              Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.

              INFORMATION SOURCES

              Primary sources

              • Manufacturers and suppliers
              • Channel partners
              • Industry experts
              • Strategic decision makers

              Secondary sources

              • Industry journals and periodicals
              • Government data
              • Financial reports of key industry players
              • Historical data
              • Press releases

              DATA ANALYSIS

              Data Synthesis

              • Collation of data
              • Estimation of key figures
              • Analysis of derived insights

              Data Validation

              • Triangulation with data models
              • Reference against proprietary databases
              • Corroboration with industry experts

              REPORT WRITING

              Qualitative

              • Market drivers
              • Market challenges
              • Market trends
              • Five forces analysis

              Quantitative

              • Market size and forecast
              • Market segmentation
              • Geographical insights
              • Competitive landscape

              PURCHASE FULL REPORT OF

              immunodiagnostics market

              QUICK BUY

              Key Questions Answered

              • What are the key global market and the regional market share?
              • What are the revenue-generating key market segments?
              • What are the key factors driving and challenging this market’s growth?
              • Who are the key market vendors and their growth strategies?
              • What are the latest trends influencing the growth of this market?
              • What are the variables influencing the market growth in the primary regions?
              • What are the factors influencing the growth of the parent market?

              Why should you prefer Technavio's market insights report?

              • Off-the-shelf research reports
              • Reports can be tailored to meet the customer's needs
              • Trusted by more than 100 fortune 500 organizations
              • Information about the market's key drivers, trends, and challenges
              • Parent market analysis
              • Every week, 50,000 people visit our subscription platform
              • Detailed vendors report with competitive landscape
              • Covid-19 impact and recovery analysis
              • Data on revenue-generating market segments
              • Details on the market shares of various regions
              • Five-force market analysis